These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 18713119)

  • 21. A systematic review and meta-analysis of systemic intraoperative anticoagulation during arteriovenous access formation for dialysis.
    Smith GE; Souroullos P; Cayton T; Harwood A; Carradice D; Chetter IC
    J Vasc Access; 2016; 17(1):1-5. PubMed ID: 26660043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical access assessment.
    Tessitore N; Bedogna V; Verlato G; Poli A
    J Vasc Access; 2014; 15 Suppl 7():S20-7. PubMed ID: 24817450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why "fistula first" matters: increased durability, less interventions, and decreased costs.
    Bazan HA
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):22. PubMed ID: 20020432
    [No Abstract]   [Full Text] [Related]  

  • 24. Points to remember: Cardiovascular consequences of hemodialysis vascular accesses.
    Su SH
    Methodist Debakey Cardiovasc J; 2014; 10(3):202-3. PubMed ID: 25574352
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of systemic anticoagulation in patients undergoing angioaccess surgery.
    D'Ayala M; Smith RM; Martone C; Briggs W; Deitch JS; Wise L
    Ann Vasc Surg; 2008 Jan; 22(1):11-5. PubMed ID: 18055171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dipyridamole plus aspirin and hemodialysis graft patency.
    Hentschel DM
    N Engl J Med; 2009 Aug; 361(7):720-1; author reply 721. PubMed ID: 19681176
    [No Abstract]   [Full Text] [Related]  

  • 27. Living the dream of no restenosis.
    Teirstein PS
    Circulation; 2001 Oct; 104(17):1996-8. PubMed ID: 11673334
    [No Abstract]   [Full Text] [Related]  

  • 28. Biological mechanisms influencing prosthetic bypass graft patency: possible targets for modern graft design.
    Scharn DM; Daamen WF; van Kuppevelt TH; van der Vliet JA
    Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):66-72. PubMed ID: 22001149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet therapy and vascular-access patency.
    Lok CE
    N Engl J Med; 2009 May; 360(21):2240-2. PubMed ID: 19458370
    [No Abstract]   [Full Text] [Related]  

  • 30. Multidisciplinary management of vascular access for haemodialysis: from the preparation of the initial access to the treatment of stenosis and thrombosis.
    Reinhold C; Haage P; Hollenbeck M; Mickley V; Ranft J
    Vasa; 2011 May; 40(3):188-98. PubMed ID: 21638247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of arteriovenous accesses with the use of duplex Doppler ultrasonography.
    Malik J; Kudlicka J; Novakova L; Adamec J; Malikova H; Kavan J
    J Vasc Access; 2014; 15 Suppl 7():S28-32. PubMed ID: 24817451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dipyridamole plus aspirin and hemodialysis graft patency.
    Weale AR; Cooper DG
    N Engl J Med; 2009 Aug; 361(7):720; author reply 721. PubMed ID: 19675337
    [No Abstract]   [Full Text] [Related]  

  • 33. Notes on angiotensin inhibition and vascular access survival: time for randomized controlled trials.
    Diskin CJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):823; author reply 824. PubMed ID: 16401624
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of drugs on arteriovenous vascular access dysfunction.
    Lee T; Lok CE
    J Vasc Access; 2015; 16 Suppl 9():S61-5. PubMed ID: 25751553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A European perspective on the Dialysis Access Consortium (DAC) study regarding the effects of clopidogrel on early failure of arteriovenous fistulas for hemodialysis.
    Chemla ES; Morsy M
    J Vasc Access; 2008; 9(4):229-30. PubMed ID: 19085890
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
    Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
    Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant medical therapy to improve patency rate following reconstruction for atherosclerosis obliterans (ASO).
    Lepäntalo M
    Acta Chir Scand Suppl; 1990; 555():51-8. PubMed ID: 2195832
    [No Abstract]   [Full Text] [Related]  

  • 38. Vascular access: a never-ending story.
    Hedin U
    J Cardiovasc Surg (Torino); 2014 Dec; 55(6):793-801. PubMed ID: 25216217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of hemodialysis graft patency by intragraft pressure measurements: prognostic or reflective?
    Leesar MA
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):212-3. PubMed ID: 20665864
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of clopidogrel on arteriovenous fistulas for dialysis.
    Wusirika R; Rao P
    JAMA; 2008 Oct; 300(14):1647; author reply 1648-9. PubMed ID: 18840831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.